Literature DB >> 28666773

Cyclocheck: a new web-based software for the assessment of objective cyclodeviation.

Justyna Simiera1, Piotr Loba2.   

Abstract

PURPOSE: To present a novel, free, web-based software tool (www.cyclocheck.com) for the assessment of objective cyclodeviation, based on measuring the disk-foveal angle (DFA) and to evaluate reproducibility of the results.
METHODS: Digital fundus photographs of both eyes of all study subjects were obtained using DRS CenterVue nonmydriatic fundus camera. Four separate measurements were made for each eye, and the DFA was calculated using Cyclocheck software independently by two observers to determine reproducibility and repeatability of the technique. The results were statistically analyzed using the interclass correlation coefficient (ICC) and the Bland-Altman method.
RESULTS: A total of 32 subjects (mean age, 34.4; range, 12-83) were enrolled: 18 were orthophoric; 14, strabismic. The ICC for the intraobserver repeatability for one observer was 0.979 (95% CI, 0.970-0.985; P < 0.0005) and for the other was 0.988 (95% CI, 0.983-0.991; P < 0.0005). The ICC for the interobserver agreement was 0.994 (95% CI, 0.992-0.996; P < 0.0005), indicating high reproducibility of the measurements.
CONCLUSIONS: Cyclocheck can assess ocular torsion quickly and easily. It provides reliable and reproducible measurements of the DFA and thus objective cyclodeviation in both orthophoric and strabismic subjects.
Copyright © 2017 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28666773     DOI: 10.1016/j.jaapos.2017.02.009

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  1 in total

1.  Automated measurement of the disc-fovea angle based on DeepLabv3.

Authors:  Bo Zheng; Yifan Shen; Yuxin Luo; Xinwen Fang; Shaojun Zhu; Jie Zhang; Maonian Wu; Ling Jin; Weihua Yang; Chenghu Wang
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.